[Studies on mechanism of hyperglycemic action of 1-(p-chlorophenylsulfonyl)-2-imidazolidinone (CPSI). II. Influence of 1-(p-chlorophenylsulfonyl)-2-imidazolidinone (CPSI) on carbohydrate and lipid metabolism (author's transl)].
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D050260:Carbohydrate Metabolism; D002747:Chlorpropamide / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006003:Glycogen / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology*; D050356:Lipid Metabolism; D051381:Rats; D013450:Sulfones / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007093:Imidazoles; D013450:Sulfones; D014280:Triglycerides; C011196:1-(4-chlorophenylsulfonyl)-2-imidazolidinone; D006003:Glycogen; D002784:Cholesterol; D002747:Chlorpropamide